Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Medscape Oncology Global - Targets of Antibody-Drug Conjugates in NSCLC: Diagnostics, Emerging Therapies, and Future Prospects

Preparing the Clinics and Future Prospects

Date

12 Sep 2022

Session

Medscape Oncology Global - Targets of Antibody-Drug Conjugates in NSCLC: Diagnostics, Emerging Therapies, and Future Prospects

Topics

Targeted Therapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Enriqueta Felip

Authors

E. Felip

Author affiliations

  • Medical Oncology Service (lung Cancer Unit)  , Vall d'Hebron University Hospital, 8035 - Barcelona/ES
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.